| Report ID | 254610 |
| Drug Identification Number | 02517132 |
| Brand name | DEXTROSE INJECTION |
| Common or Proper name | DEXTROSE INJECTION USP |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 50% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 x 50mL vial / fiole |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2025-04-30 |
| Estimated end date | 2026-02-09 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-13 |
| Company comments | Product is on allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | [email protected] - 1-800-363-0584 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v28 | 2026-01-13 | English | Compare |
| v27 | 2026-01-06 | French | Compare |
| v26 | 2026-01-06 | English | Compare |
| v25 | 2025-12-17 | French | Compare |
| v24 | 2025-12-17 | English | Compare |
| v23 | 2025-10-21 | French | Compare |
| v22 | 2025-10-21 | English | Compare |
| v21 | 2025-09-09 | French | Compare |
| v20 | 2025-09-09 | English | Compare |
| v19 | 2025-09-03 | French | Compare |
| v18 | 2025-09-03 | English | Compare |
| v17 | 2025-08-29 | French | Compare |
| v16 | 2025-08-29 | English | Compare |
| v15 | 2025-08-11 | French | Compare |
| v14 | 2025-08-11 | English | Compare |
| v13 | 2025-07-09 | French | Compare |
| v12 | 2025-07-09 | English | Compare |
| v11 | 2025-06-26 | French | Compare |
| v10 | 2025-06-26 | English | Compare |
| v9 | 2025-05-16 | French | Compare |